Skip to main content

FLUENT Cannabis Applauds Historic Federal Rescheduling of Cannabis

Written by Customer Service on . Posted in Public Companies.

Schedule III action affirms medical legitimacy and advances a more regulated national cannabis market

TAMPA, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) — FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today applauds the historic federal action directing the rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act, a landmark policy shift that formally recognizes cannabis’s accepted medical use and represents a critical step toward a more rational and regulated national cannabis framework.

“Federal rescheduling is a pivotal moment for patients, operators, and investors,” said David Vautrin, Interim CEO of FLUENT. “We applaud the Administration for recognizing the therapeutic benefits of cannabis-based medicine and advancing common-sense reforms, including 280E relief.”

Schedule III status will reduce federal policy barriers, improve access to banking, and allow companies to deduct ordinary business expenses previously disallowed under 280E, freeing capital for patient care, product innovation, and market expansion.

This rescheduling follows recent federal clarification around hemp-derived intoxicants passed on November 12th, 2025. This action materially shuts down the depth and reach of intoxicating hemp derived Cannabis by November 2026. This is expected to reduce unlicensed competition and ease pricing pressure enterprise wide with the greatest impact in key FLUENT states such as Florida and the potential in Texas.

“While rescheduling represents meaningful progress, there remains important work ahead to fully resolve the conflict between state and federal law and to advance broader criminal justice reforms,” Vautrin added. “FLUENT remains committed to operating responsibly within the regulatory framework while supporting continued policy evolution that benefits patients, communities, and investors.”

About FLUENT Corp.

FLUENT, a national cannabis consumer packaged goods company and retailer, is dedicated to being one of the highest quality cannabis companies for the communities it serves. This is driven by FLUENT’s unrelenting commitment to operational excellence in cultivation, production, distribution, and retail experience. FLUENT produces an assortment of cannabis products under a diverse portfolio of brands including MOODS, Knack, Wandr, Bag-O and Hyer Kind. FLUENT operates in Florida, New York, Pennsylvania, and Texas. Headquartered in Tampa, Florida, FLUENT employs 700 employees across 8 cultivation and manufacturing facilities, 37 active retail locations and a wholesale division which trades under ENTOURAGE servicing third party retailers in New York. For more information on the Company’s wholesale division ENTOURAGE, please visit https://entouragewholesale.com/.

FLUENT’s Common Shares trade on the Canadian Securities Exchange under the symbol “FNT.U” and on the OTCQB Venture Market under the symbol “CNTMF”. For more information about the Company, please visit www.getFLUENT.com.

Investor Relations Contact

investors@getFLUENT.com

Media Contact:

press@getFLUENT.com

Officer Contact:

Matt Mundy, Chief Legal Officer

(850) 972-8077

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.